| (GBp) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, FARN.L returned -81.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -77.2% |
| 1 year | -81.8% |
| 5 years | -90.3% |
| 10 years | -83.6% |
| All-time high | GBX 882.32 (Feb 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what £1,000 in FARN.L would be worth today ›No. Faron Pharmaceuticals Oy has not paid a dividend in the past 12 months.
Faron Pharmaceuticals Oy is part of the Healthcare sector.
Faron Pharmaceuticals Oy has a market cap of 83.18M GBp, based on the latest quote.
Faron Pharmaceuticals Oy is scheduled to report earnings on Aug 26, 2026.
